1. Home
  2. Labeler Index
  3. Takeda Pharmaceuticals America, Inc.
  4. 0944-2884
  5. NDC Package Code: 0944-2884-01 Glassia

NDC Package 0944-2884-01 Glassia

.alpha.1-proteinase Inhibitor Human Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0944-2884-01
Package Description:
1 VIAL, GLASS in 1 CARTON / 50 mL in 1 VIAL, GLASS (0944-2884-02)
Product Code:
0944-2884
Proprietary Name:
Glassia
Non-Proprietary Name:
.alpha.1-proteinase Inhibitor Human
Substance Name:
.alpha.1-proteinase Inhibitor Human
Usage Information:
This medication is used to treat lung problems (emphysema) caused by a certain inherited disease (alpha-1-proteinase inhibitor deficiency). In people with this condition, lung damage is caused by elastase, a natural substance that the body needs to kill bacteria in the lungs. Normally, a protein (alpha-1-proteinase inhibitor) stops elastase from working when it is no longer needed. However, in people who do not make enough of this protein, elastase does not stop working and damages the lungs. This medication replaces the missing alpha-1-proteinase inhibitor and helps to prevent further lung damage.
11-Digit NDC Billing Format:
00944288401
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1013867 - Glassia 1 MG Injection
  • RxCUI: 1013867 - alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
  • RxCUI: 1661208 - alpha 1-proteinase inhibitor, human 1 MG Injection
    • Product Type:
    Plasma Derivative
    Labeler Name:
    Takeda Pharmaceuticals America, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • .ALPHA.1-PROTEINASE INHIBITOR HUMAN 1 g/50mL
    • Pharmacologic Class(es):
  • Human alpha-1 Proteinase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Trypsin Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    BLA125325
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    07-01-2010
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0944-2884-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00944288401J0257Glassia injection10 MG110.10.1

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0944-2884-01?

    The NDC Packaged Code 0944-2884-01 is assigned to a package of 1 vial, glass in 1 carton / 50 ml in 1 vial, glass (0944-2884-02) of Glassia, a plasma derivative labeled by Takeda Pharmaceuticals America, Inc.. The product's dosage form is injection, solution and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 0944-2884 included in the NDC Directory?

    Yes, Glassia with product code 0944-2884 is active and included in the NDC Directory. The product was first marketed by Takeda Pharmaceuticals America, Inc. on July 01, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0944-2884-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0944-2884-01?

    The 11-digit format is 00944288401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20944-2884-015-4-200944-2884-01